Navigation Links
Inflammation Can't Explain Depression's Link to Heart Disease
Date:11/15/2007

Other factors must be at play to raise women's risk, researchers say

THURSDAY, Nov. 15 (HealthDay News) -- Depression is known to hike the risk of cardiovascular disease, but don't put all the blame on any concurrent rise in inflammation.

So concludes a study led by Dr. Viola Vaccarino, a professor of medicine at Emory University, in Atlanta.

That means that it's back to the drawing board in terms of unraveling the depression-heart disease link, according to Vaccarino.

"That depression is a factor in cardiovascular disease is clear. What is not clear is what kind of mechanism is involved," she said.

The Emory group, as well as researchers from five other medical institutions, studied the possible role of inflammation in a group of 559 women who were referred for heart tests because of blockage in a coronary artery. All the women had a standard test for depression at the start of the study and were followed for an average of about six years.

They were divided into three groups on the basis of those tests: those who clearly were depressed by diagnosis and previous treatment; those who might be depressed because of either a diagnosis or treatment; and those who had no indicator of depression.

The researchers made frequent measurements of two molecules linked to the inflammatory response -- C-reactive protein (CRP) and interleukin-6.

There were 79 major events of cardiovascular disease during the study, 23 of them fatal.

As expected, the incidence of such events was 2.5 times higher in women with depression. There was no comparable increase in women classified as possibly depressed.

The team found that women diagnosed as depressed had a 70 percent higher level of C-reactive protein and a 25 percent higher level of interleukin-6 compared to women who were not depressed. Women classified as possibly depressed had elevated levels of both markers, but to a lesser extent.

The bottom line, according to the researchers, was that while inflammation was tied to heart risk, it failed to explain most of the cardiovascular danger posed by depression.

"Despite being associated with each other, depression and inflammation predicted future events for the large part independently," the researchers wrote. "Thus, despite a clear relationship between depression and inflammation, the latter plays only a minor role in the higher risk of adverse outcomes for women with depression."

The finding is something of as surprise, said Dr. David S. Sheps, professor of medicine at the University of Florida at Gainesville, a member of the research team.

"We know from other studies that there is a relationship between depression and elevation of certain inflammatory molecules, but no one knows for sure what the mechanism is," Sheps said.

"What is clear is that inflammation does not play a substantial role," Vaccarino said. "We need to look at other things. Perhaps there is a change in the ability of platelets to aggregate." Platelets are blood cells that can form clots to block arteries. "And there could be other pathways," she said.

More information

There's more on C-reactive protein and heart disease at the American Heart Association.



SOURCES: Viola Vaccarino, M.D., Ph.D., professor, medicine, Emory University, Atlanta; David S. Sheps, M.D., professor, medicine, University of Florida, Gainesville; November 2007 Journal of the American College of Cardiology


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. New insights into inflammation in osteoarthritis
3. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
4. Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
5. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
6. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
7. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
8. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
9. Study shows adverse drug events reported to the FDA have significantly increased
10. Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs
11. Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Inflammation Can't Explain Depression's Link to Heart Disease
(Date:8/16/2017)... ... August 16, 2017 , ... The Data ... today that it was acquired by Advantage Solutions. The Data Council’s IX-ONE ... members include the industry’s leading suppliers, brokers, distributors and retailers. The Data Council ...
(Date:8/16/2017)... Va. (PRWEB) , ... August 16, 2017 , ... ... America (BIAA) is collaborating with a New England student to educate the public ... to acclaim in 2016 for launching the first-ever National Concussion Awareness Day. , ...
(Date:8/16/2017)... New York (PRWEB) , ... August 16, 2017 , ... ... could minimize its appearance with diet and exercise. In fact, cellulite can't always be ... a safer and more effective treatment available to select physicians nationwide. Dr. Kenneth Rothaus ...
(Date:8/16/2017)... ... 16, 2017 , ... Modern Consulting Insurance & Financial Services ... once again with Boys & Girls Clubs of Greater Kansas City, the agency ... own American Idol. With all proceeds benefitting local worthy causes, donations may be ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... received a three-year grant totaling $975,000, renewing its funding from the Health Resources ... Services. , This funding marks, the fourth time the HRSA administration has renewed ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... Aug. 1, 2017   CerSci Therapeutics , a ... Texas , has received notice from the National ... of Health (NIH) that it has been awarded a ... over $650,000 in 2017 with an additional $1,000,000 to ... New Drug application of their lead non-opioid drug candidate ...
(Date:7/28/2017)... --EnvoyHealth, a Diplomat company, has partnered with Compliance Meds ... a technology designed to improve patient medication adherence. ... solutions and services that help track and improve patients, ... LITE offers medication monitoring and control for patients and ... Records date and time of bottle ...
(Date:7/26/2017)... BEACH, Fla. , July 26, 2017 ... of enrollment of our clinical trial evaluating Altemia TM ... Cell Anemia (SCA) and Sickle Cell Disease (SCD). The ... to evaluate the efficacy and safety of Altemia TM ... trial is conducted under US IND 125274. ...
Breaking Medicine Technology: